Good afternoon and welcome to Markets Desk, your midday read on what's moving markets and policy.
Secretary of State Marco Rubio is heading to Reliance Industries' Jamnagar refinery in Gujarat, a visit that carries real weight as U.S. diesel prices climb. Mukesh Ambani's operation has emerged as a key supply lever, with Reliance buying Venezuelan crude and now eyeing a stake in American refining capacity — putting energy diplomacy squarely on the table.
Shifting to the Fed, dollar bulls took a step back after Kevin Warsh, speaking at IMF meetings in Washington, declined to signal any rate move in October. That comes after recent inflation data had traders pricing in back-to-back hikes, so Warsh's silence was itself a message — and the greenback softened in response, easing pressure on risk assets globally.
And in pharma, Roche cleared a meaningful regulatory hurdle with FDA approval of Enspryng for thyroid eye disease in adults. The drug can be self-administered following provider training, which broadens its commercial reach considerably. Investors will be watching how quickly Roche can convert that approval into prescription volume in what remains a relatively underserved patient population.
That's the tape. Markets Desk, signing off the floor.
